awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49335901-30710896-8F3D-4D86-AB8C-6416D1977500
Q49335901-30710896-8F3D-4D86-AB8C-6416D1977500
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49335901-30710896-8F3D-4D86-AB8C-6416D1977500
Refractory thyroid carcinoma: which systemic treatment to use?
P2860
Q49335901-30710896-8F3D-4D86-AB8C-6416D1977500
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49335901-30710896-8F3D-4D86-AB8C-6416D1977500
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
38a634431343a7845a902a38eb468e7590b630bf
P2860
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyr